Clinical Trials in Philadelphia

Showing 8481-8500 of 15,860 trials

Early FDG PET in Melanoma

NCT02716077

Adult patients with histologically proven melanoma who will be treated with pembrolizumab will undergo FDG PET/CT scan as an early evaluation of response to therapy. Changes in FDG uptake will be correlated with lab and pathology results.

Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma

Abramson Cancer Center at Penn Medicine6 participantsStarted Mar 2016

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease

NCT02307513

The main objective of this study is to evaluate the efficacy and safety of apremilast in the treatment of oral ulcers in adults with active Behçet's disease (BD).

Behçet's Syndrome

Amgen207 participantsStarted Dec 2014

Phoenix, Arizona, United States • Sacramento, California, United States • Ormond Beach, Florida, United States +60 more locations

Early FDG PET in Melanoma

A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease

Find Trials by Condition in Philadelphia

The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion

Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects

Natural History Study of MNGIE

Phase 2/3 Study of IGSC, 20% in PIDD

A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

Breast Mesh Used in Two-staged Breast Reconstruction

Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A